Pete Finan is a Partner at Epidarex Capital. He has more than twenty years of experience in drug discovery within the pharmaceutical industry, having served as head of the Novartis Institute of BioMedical Research (NIBR) site in the UK where he oversaw the activities of 350 scientists and clinicians working in the respiratory disease area. Prior to this he was an Executive Director in the Developmental and Molecular Pathways department at NIBR in Cambridge, Massachusetts leading programs in oncology, inflammation and regenerative medicine.  Pete is currently CEO of oncology drug discovery company AdoRx Therapeutics. He has co-led the financing of six new companies in the Epidarex portfolio and holds Board positions with Enterprise Therapeutics, IGEM Therapeutics, Leucid Bio and Clyde Biosciences. He is a member of the Board of Directors and Scientific Advisory Board of the Keystone Symposia.